DynaMed® and Datapharm Partnership Provides Health Care Professionals Access to Medicines Information

~ Collaboration Enhances Accessibility and Usability of United Kingdom Drug Content ~

IPSWICH, Mass. — December 17, 2020 — DynaMed®, EBSCO Information Services’ (EBSCO) flagship clinical decision support tool, has partnered with Datapharm. The medicines information company provides technology-enabled solutions to the global life sciences and wider health care sectors. The partnership allows EBSCO and Datapharm to integrate electronic medicines compendium (emc) into DynaMed and DynaMed® and Micromedex® with Watson.

Datapharm is trusted by medical professionals as a global source for accessible, regulated United Kingdom (UK) medicines information. emc contains more than 18,000 documents, primarily Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), all of which have been checked and approved by either the UK Medicines and Healthcare Products Regulatory Agency (MHRA) or the European Medicines Agency (EMA).

DynaMed provides the most current, accurate, actionable answers to clinical questions at the point of care. DynaMed and Micromedex with Watson, a single solution through a partnership between EBSCO and IBM, combines curated disease information with top evidence-based drug content. These solutions aim to improve health care outcomes worldwide, offering the most current and accurate, evidence-based content to practicing clinicians.

Datapharm’s Director, Nat Knight, says Datapharm is passionate about providing accessible, accurate non-promotional medical information to support health care decision-making. “Our partnership with DynaMed responds to the fragmented information available online by offering accurate and reliable content that supports and enhances health care professionals throughout the clinical decision-making process.”

EBSCO Information Services Director, Global Clinical Solutions, Sue Campbell says this partnership will enhance the already-robust drug content in DynaMed and DynaMed and Micromedex with Watson. “The integration of Datapharm’s trusted drug information content will help inform delivery of personalized patient care. In today’s environment, clinicians need access to fast and reliable content when, where and how they need it.”

About EBSCO Information Services
EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; health care and medical institutions; corporations; and government agencies around the world. EBSCO’s Clinical Decisions suite of products are designed to improve patient care by providing health care professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. EBSCO Information Services is a division of EBSCO Industries, Inc., a family owned company since 1944. For more information, visit the EBSCO website at: www.ebsco.com.

About Datapharm
Datapharm is the leading medicines information company in the UK that provides accurate medical information accessible to patients and healthcare professionals. Formed in 1977 to publish medicines information on behalf of the pharmaceutical industry, it now runs emc (electronic medicines compendium) which has become the UK’s most comprehensive, trusted and accessible source of information about medicines.

Datapharm works in partnership with a wide range of organizations including the NHS, the Medicines and Healthcare products Regulatory Agency (MHRA), European Medicines Agency (EMA) and the Department of Health & Social Care (DHSC). For more information, visit the Datapharm website at: www.datapharm.com.


For more information, please contact:
Jessica Holmes
EBSCO Information Services
Communications Director

Valentina Sidore
Datapharm Ltd
Product Marketing Manager

Share this: